AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 3.19 |
Market Cap | 92.39M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -116.14 |
PE Ratio (ttm) | -0.03 |
Forward PE | n/a |
Analyst | Hold |
Ask | 3.98 |
Volume | 179,780 |
Avg. Volume (20D) | 344,286 |
Open | 3.70 |
Previous Close | 3.64 |
Day's Range | 3.37 - 3.79 |
52-Week Range | 2.65 - 16.52 |
Beta | undefined |
About ME
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact respo...
Analyst Forecast
According to 1 analyst ratings, the average rating for ME stock is "Hold." The 12-month stock price forecast is $9.4, which is an increase of 178.11% from the latest price.
Next Earnings Release
Analysts project revenue of $54.30M, reflecting a 21.35% YoY growth and earnings per share of -0.16, making a -95.00% decrease YoY.
2 months ago · proactiveinvestors.co.uk
23andMe to cut 40% of its workforce as it looks to stablise the businessGenetic testing firm 23andMe announced plans to cut 40% of its workforce, or around 200 jobs, as part of a cost-saving effort aimed at stabilising the company. It will also halt work on its therapy de...